维普中文期刊产品整合服务
207篇 您的检索式:作者名="Henry RR"
    题名 作者 年代 出处 被引量
1New oral therapies for type 2 diabetes mellitus:The glitazones or insulin sensitizers显示文摘Mudaliar S Henry RR 2001Annu Rev Med2001,52,:1
2Effects of varying carbohydrate content of diet in patients with non - insulin dependent diabetes mellitus 显示文摘Grag A Bantle JP Henry RR 1994JAMA1994,271,18:1
3Insulin resistance : from predisposing factor to therapeutic target in type 2 diabetes显示文摘Henry RR 2003Clin Ther2003,25,:1
4The role of incretins in cardiovascular control显示文摘Mafong DD Henry RR 2009Curr Hypertens Rep2009,11,1:1
5Creating, characterizing, and controlling chemistry with SERS hot spots显示文摘Kleinman SL Frontiera RR Henry AI 2013Phys Chem Chem Phys2013,15,1:1
6Vascular endothelial growth factor restores corporeal smooth muscle function in vitro显示文摘Byrne RR Henry GD Rao DS 2001J Urol2001,165,4:1
7Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Re- view显示文摘ARODA VR HENRY RR HAN J 2012Clin Ther2012,34,6:1
8Primary malignant lym- phomas of the central nervous system 显示文摘Henry JM Heffner RR Jr Dillard SH 1974Cancer1974,34,:1
9Effects of exenatide (exendin -4) on glycemic control over 30 weeks in sulfonylurea - treated patients with type 2 diabetes 显示文摘Buse JB Henry RR Hart J 2004Diabetes Care2004,27,:1
10Glucose control and insulin resistance in non-insulindependent diabetes mellitus显示文摘Henry RR 1996Ann Intern Med1996,124,12:1
11Dapagliflozin, metformin XR, or both : initial pharmacotherapy for type 2 diabetes, a randomised controlled trial 显示文摘Henry RR Murray AV 2012Int J Clin Pract2012,5,:1
12Incretin therapies:effects beyond glycemic control显示文摘Mudaliar S Henry RR 2009Am J Med2009,122,6:1
13Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease显示文摘Mudaliar S Henry RR Sanyal A J 2013Gastroenterology2013,145,:1
14Acquired defects of glycogen synthase activity in cultured hunan skeletal muscle cells: influence of high glucose and insulin levels显示文摘Henry RR Ciaraldi TP Mudaliar S 1996Diabetes1996,45,:1
15Effects of exenatide (exendin-4)on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes显示文摘Buse JB Henry RR Han J 2004Diabet Care2004,27,:1
16Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes 显示文摘Henry RR 2003Chin Ther2003,25,:1
17New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)显示文摘Henry RR Chilton R Garvey WT 2013J Diabetes Complications2013,27,:1
18Effects of exenatide(exendin-4)on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes显示文摘Buse JB Henry RR Han J 2004Diabetes Care2004,27,11:1
19Longer acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature显示文摘TIBBLE CA CAVAIOLA TS HENRY RR 2013Endocrinol Metab2013,8,3:1
20SGLT2 inhibition -- a novel strategy for diabetes treatment 显示文摘Chao EC Henry RR 2010Nat Rev Drug Discov2010,9,7:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费